Events Pharma
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Tagg MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Tagg MV 1mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tagg MV 1mg/500mg/0.3mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Tagg MV 1mg/500mg/0.3mg Tablet.
Tagg MV 1mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Tagg MV 1mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Tagg MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Tagg MV 1mg/500mg/0.3mg Tablet is a combination of Glimepiride, Metformin and Voglibose. This medication is prescribed to manage type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken with proper diet and exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production by the liver and improves insulin sensitivity, while Voglibose inhibits alpha-glucosidase to lower postprandial glucose levels after meals. This combination is not indicated for Type 1 DM.
Possible side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
This medication should not be used if you have known allergies to any components or excipients of this medicine, or have severe kidney disease, inflammatory bowel disease with colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, combining alcohol and Tagg MV 1mg/500mg/0.3mg Tablet is not recommended. It may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Tagg MV 1mg/500mg/0.3mg Tablet may cause hypoglycemia (low blood sugar level). Common symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to happen if you miss meals, drink alcohol, over-exercise, or take other diabetes medications with it. Regular monitoring of blood sugar levels is essential. Always keep glucose tablets, honey, or fruit juice on hand.
Store this medication in its original container with the label intact. Keep it away from children, pets, and other unauthorized individuals. Dispose of unused medication safely according to local regulations.